Cargando…
Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272248/ https://www.ncbi.nlm.nih.gov/pubmed/37246202 http://dx.doi.org/10.1007/s12325-023-02542-w |
| _version_ | 1785059453154885632 |
|---|---|
| author | Ghislain, Pierre-Dominique Lambert, Jo Lam Hoai, Xuãn-Lan Hillary, Tom Roquet-Gravy, Pierre-Paul de la Brassinne, Michel Segaert, Siegfried |
| author_facet | Ghislain, Pierre-Dominique Lambert, Jo Lam Hoai, Xuãn-Lan Hillary, Tom Roquet-Gravy, Pierre-Paul de la Brassinne, Michel Segaert, Siegfried |
| author_sort | Ghislain, Pierre-Dominique |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10272248 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102722482023-06-17 Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study Ghislain, Pierre-Dominique Lambert, Jo Lam Hoai, Xuãn-Lan Hillary, Tom Roquet-Gravy, Pierre-Paul de la Brassinne, Michel Segaert, Siegfried Adv Ther Correction Springer Healthcare 2023-05-29 2023 /pmc/articles/PMC10272248/ /pubmed/37246202 http://dx.doi.org/10.1007/s12325-023-02542-w Text en © Springer Healthcare Ltd., part of Springer Nature 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Ghislain, Pierre-Dominique Lambert, Jo Lam Hoai, Xuãn-Lan Hillary, Tom Roquet-Gravy, Pierre-Paul de la Brassinne, Michel Segaert, Siegfried Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study |
| title | Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study |
| title_full | Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study |
| title_fullStr | Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study |
| title_full_unstemmed | Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study |
| title_short | Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study |
| title_sort | correction to: real-life effectiveness of apremilast for the treatment of psoriasis in belgium: results from the observational otelo study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272248/ https://www.ncbi.nlm.nih.gov/pubmed/37246202 http://dx.doi.org/10.1007/s12325-023-02542-w |
| work_keys_str_mv | AT ghislainpierredominique correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy AT lambertjo correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy AT lamhoaixuanlan correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy AT hillarytom correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy AT roquetgravypierrepaul correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy AT delabrassinnemichel correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy AT segaertsiegfried correctiontoreallifeeffectivenessofapremilastforthetreatmentofpsoriasisinbelgiumresultsfromtheobservationalotelostudy |